On December 15, 2022, James T. LaFrance resigned from the board of directors of Aspira Women's Health Inc., effective immediately. Following Mr. LaFrance's resignation, the Board appointed Dr. Robert Auerbach to the Audit Committee of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.234 USD | -4.10% | -16.00% | -45.24% |
15/05 | Transcript : Aspira Women's Health Inc., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Reports Q1 Revenue $2.2M, vs. Street Est of $2.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.24% | 28.77M | |
-29.40% | 9.98B | |
+27.00% | 2.87B | |
-17.50% | 2.07B | |
-24.32% | 1.59B | |
+66.18% | 1.43B | |
+39.17% | 824M | |
-5.02% | 733M | |
-30.00% | 508M | |
+0.20% | 296M |
- Stock Market
- Equities
- AWH Stock
- News Aspira Women's Health Inc.
- Aspira Women's Health Inc. Announces Executive Changes